Inflammopharmacology

Inflammopharmacology英文簡介

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:

-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states

-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs

-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents

-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain

-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs

-Muscle-immune interactions during inflammation [...]

Inflammopharmacology中文簡介

《Inflammopharmacology》是一本由SPRINGER BASEL AG出版商出版的專業醫學期刊，該刊創刊于1991年，刊期6 issues per year，該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 3區，小類學科：免疫學 3區；毒理學 3區；在JCR（Journal Citation Reports）分區等級為Q1。該刊發文范圍涵蓋免疫學等領域，旨在及時、準確、全面地報道國內外免疫學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為5.093，

中科院分區最新升級版（當前數據版本：2021年12月最新升級版）

大類學科	分區	小類學科	分區	Top期刊	綜述期刊
醫學	3區	IMMUNOLOGY 免疫學 TOXICOLOGY 毒理學	3區 3區	否	否

中科院分區最新基礎版（當前數據版本：2021年12月最新基礎版）

大類學科	分區	小類學科	分區	Top期刊	綜述期刊
醫學	3區	IMMUNOLOGY 免疫學 TOXICOLOGY 毒理學	3區 2區	否	否

中科院JCR分區歷年趨勢圖

JCR分區（當前數據版本：2021-2022年最新版）

JCR分區等級	JCR所屬學科	分區	影響因子
Q1	TOXICOLOGY	Q1	5.093
	IMMUNOLOGY	Q2

期刊指數

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
5.093	45	5.49%	70.48%	未開放	--

IF值(影響因子)趨勢圖